{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:11:18Z","timestamp":1765887078121},"reference-count":54,"publisher":"Frontline Medical Communications, Inc.","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.sder.2008.07.001","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T11:12:44Z","timestamp":1221045164000},"page":"183-187","source":"Crossref","is-referenced-by-count":38,"title":["Antibiotic Treatment for Acne Vulgaris"],"prefix":"10.12788","volume":"27","author":[{"given":"Guy F.","family":"Webster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmy M.","family":"Graber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2008.07.001_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/bmj.325.7362.475","article-title":"Acne vulgaris","volume":"325","author":"Webster","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.sder.2008.07.001_bib2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archderm.1963.01590240156026","article-title":"The pathogenic role of Corynebacterium acnes in acne vulgaris","volume":"88","author":"Kirschbaum","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1126\/science.1100330","article-title":"The complete genome sequence of Propionibacterium acnes, a commensal of human skin","volume":"305","author":"Br\u00fcggemann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.sder.2008.07.001_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000067821","article-title":"Update and future of systemic acne treatment","volume":"206","author":"Zouboulis","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.sder.2008.07.001_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1346-8138.2001.tb00077.x","article-title":"Azithromycin monthly pulse vs daily doxycyline in the treatment of acne vulgaris","volume":"28","author":"Parsad","year":"2001","journal-title":"J Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0190-9622(83)70005-8","article-title":"Propionibacterium acnes resistance to antibiotics in acne patients","volume":"8","author":"Leyden","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2133.2001.03956.x","article-title":"Phenotypic and genotypic characterization of antibiotic resistant Propionibacterium acnes isolated from acne patients attending dermatology clinicsin Europe, the USA, Japan and Australia","volume":"144","author":"Ross","year":"2001","journal-title":"Br J Derm"},{"key":"10.1016\/j.sder.2008.07.001_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/000155502320323216","article-title":"Bacterial resistance and outcome following three months of topical acne therapy with 2% erythromycin gel vs its vehicle","volume":"82","author":"Mills","year":"2002","journal-title":"Acta Dermatol Venerol"},{"key":"10.1016\/j.sder.2008.07.001_bib10","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/AAC.40.11.2598","article-title":"Effects of topical erythromycin on the ecology of aerobic cutaneous bacterial flora","volume":"40","author":"Vowels","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.sder.2008.07.001_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00128071-200102040-00007","article-title":"The combination formulation of clindamycin 1% plus benzoyl peroxide 5% vs. three different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes","volume":"4","author":"Leyden","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib12","first-page":"545","article-title":"Further evidence for the role of bivalent cations in human polymorphonuclear leukocyte locomotion","volume":"25","author":"Goodheart","year":"1979","journal-title":"J Reticuloendothelial Soc"},{"key":"10.1016\/j.sder.2008.07.001_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/archderm.1994.01690060078008","article-title":"Inhibition of a model of granuloma formation by tetracyclines and ciprofloxacin: Involvement of protein kinase C","volume":"130","author":"Webster","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1086\/517383","article-title":"Doxycycline reduces mortality to lethal endotoxemia by reducing nitric oxide synthesis via an interleukin-10-independent mechanism (Erratum in: J Infect Dis 177:1778, 1998)","volume":"177","author":"D'Agostino","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.sder.2008.07.001_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0765.1983.tb00388.x","article-title":"Minocycline reduces gingival collagenolytic activity during diabetes","volume":"18","author":"Golub","year":"1983","journal-title":"J Perio Res"},{"key":"10.1016\/j.sder.2008.07.001_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00417-005-0212-3","article-title":"Tear fluid levels of MMP-8 are elevated in ocular rosacea: Treatment effect of oral doxycycline","volume":"244","author":"Maata","year":"2006","journal-title":"Graefs Arch Clin Exp Ophth"},{"key":"10.1016\/j.sder.2008.07.001_bib17","first-page":"1703","article-title":"Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant","volume":"41","author":"Sobrin","year":"2000","journal-title":"Invest Ophth Vis Sci"},{"key":"10.1016\/j.sder.2008.07.001_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: Non-antibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib19","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Ramdomized phase 2 trial of MMP inhibitor col-3 in AIDS-related Kaposi's sarcoma","volume":"24","author":"Dezube","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.sder.2008.07.001_bib20","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/ijc.21447","article-title":"Tetracyclines analogues doxycycline and col 3 induce caspase dependent and independent apoptosis in human colon cancer cells","volume":"118","author":"Onoda","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.sder.2008.07.001_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.drup.2004.04.002","article-title":"Chemically modified tetracyclines as inhibitors f matrix metalloproteinases","volume":"7","author":"Acharya","year":"2004","journal-title":"Drug Resit Updat"},{"key":"10.1016\/j.sder.2008.07.001_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2133.1981.tb15317.x","article-title":"Inhibition of lipase production in Propionibacterium acnes by sub minimal inhibitory concentrations of tetracycline and erythromycin","volume":"105","author":"Webster","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib23","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.21.5.770","article-title":"Suppression of polymorphonuclear leukoicytechemotactic factor production by sub minimal inhibitory concentrations of tetracycline, minocycline, ampicillin and erythromycin","volume":"21","author":"Webster","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.sder.2008.07.001_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2005.04.069","article-title":"A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"53","author":"Sanchez","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1902\/jop.2004.75.1.106","article-title":"The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis","volume":"75","author":"Emingil","year":"2004","journal-title":"J Periodontol"},{"key":"10.1016\/j.sder.2008.07.001_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1540-9740.2007.06460.x","article-title":"Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosacea","volume":"6","author":"Theobald","year":"2007","journal-title":"Skin Med"},{"key":"10.1016\/j.sder.2008.07.001_bib27","series-title":"Fitzpatrick's Dermatology in General Medicine","first-page":"690","article-title":"Acne vulgaris and acneiform eruptions","author":"Zaenglein","year":"2007"},{"key":"10.1016\/j.sder.2008.07.001_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2230.1993.tb02242.x","article-title":"Phototoxic eruptions due to doxycycline\u2014a dose related phenomenon","volume":"18","author":"Layton","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/S0049-0172(99)80004-3","article-title":"Minocycline induced autoimmune syndromes: An overview","volume":"28","author":"Elkayam","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.sder.2008.07.001_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bmj.2.5911.149","article-title":"Tetracycline poisoning in renal failure","volume":"2","author":"Phillips","year":"1974","journal-title":"Br Med Jr"},{"key":"10.1016\/j.sder.2008.07.001_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5694\/j.1326-5377.1998.tb140250.x","article-title":"Systematic review of Propionibacterium acnes resistance to systemic antibiotics","volume":"169","author":"Cooper","year":"1998","journal-title":"Med J Aus"},{"issue":"suppl 15","key":"10.1016\/j.sder.2008.07.001_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0926-9959.2001.00013.x","article-title":"Current issues in antimicrobial therapy for the treatment of acne","volume":"3","author":"Leyden","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2008.07.001_bib33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archderm.1982.01650240033017","article-title":"Efficacy of minocycline compared with tetracycline in treatment of acne vulgaris","volume":"118","author":"Hubbell","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09546639609089553","article-title":"The antimicrobial effects in vivo of minocycline, doxycycline and tetracycline in humans","volume":"7","author":"Leyden","year":"1996","journal-title":"J Derm Treat"},{"key":"10.1016\/j.sder.2008.07.001_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000247241","article-title":"Oral trimethoprim as a third line antibiotic in the management of acne vulgaris","volume":"187","author":"Bottomly","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.sder.2008.07.001_bib36","first-page":"59","volume":"48","author":"Sykes","year":"1994","journal-title":"Acne: A review of optimum treatment Drugs"},{"key":"10.1016\/j.sder.2008.07.001_bib37","series-title":"Cosmetic Formulation of Skin Care Products","first-page":"273","article-title":"Acne treatment methodologies","author":"Fernandez","year":"2006"},{"key":"10.1016\/j.sder.2008.07.001_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/bmj.325.7362.475","article-title":"Acne vulgaris","volume":"325","author":"Webster","year":"2002","journal-title":"Brit Med J"},{"key":"10.1016\/j.sder.2008.07.001_bib39","first-page":"670","article-title":"Post-therapeutic benzoyl peroxide contact allergy in ulcus cruris patients","volume":"36","author":"Bandmann","year":"1985","journal-title":"Hautzert"},{"key":"10.1016\/j.sder.2008.07.001_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2340\/00015555895763","article-title":"Benzoyl peroxide","volume":"60","author":"Cotterill","year":"1980","journal-title":"Acta Dermatol Venerol"},{"key":"10.1016\/j.sder.2008.07.001_bib41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-4362.1986.tb04534.x","article-title":"Comparing 2.5%, 5% and 10% benzoyl peroxide in inflammatory acne vulgaris","volume":"25","author":"Mills","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00128071-200102040-00007","article-title":"The combination formulation of clindamycin 1% plus benzoyl peroxide 5% vs. three different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes","volume":"4","author":"Leyden","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib43","first-page":"257","article-title":"Therapeutic studies with a new combination benzoyl peroxide\/clindamycin topical gel in acne vulgaris","volume":"67","author":"Ellis","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2008.07.001_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2133.1996.tb07847.x","article-title":"The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria","volume":"134","author":"Eady","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10552-005-0445-9","article-title":"Association between antibiotic use prior to breast cancer diagnosis and breast tumor characteristics","volume":"17","author":"Velicer","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.sder.2008.07.001_bib46","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.291.7.827","article-title":"Antibiotic use in relation to the risk of breast cancer","volume":"291","author":"Velicer","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.sder.2008.07.001_bib47","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archderm.141.9.1132","article-title":"Antibiotic treatment of acne may be associated with upper respiratory tract infections","volume":"141","author":"Margolis","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0190-9622(83)70005-8","article-title":"Propionibacterium acnes resistance to antibiotics in acne patients","volume":"8","author":"Leyden","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.1989.tb01399.x","article-title":"Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure","volume":"121","author":"Eady","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib50","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1365-2133.2005.06897.x","article-title":"Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne","volume":"153","author":"Coates","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib51","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0149-2918(02)80023-6","article-title":"A: randomized, double-blind comparison of a clindamycin phosphate\/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris","volume":"24","author":"Cunliffe","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.sder.2008.07.001_bib52","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","article-title":"Oral contraceptive efficacy and antibiotic interaction: A myth debunked","volume":"46","author":"Archer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.07.001_bib53","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1158\/1055-9965.EPI-06-0401","article-title":"Antibiotics and risk of breast cancer: Up to 9 years of follow-up of 2.1 million women","volume":"15","author":"Friedman","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.sder.2008.07.001_bib54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pds.1512","article-title":"Risk of breast cancer in relation to antibiotic use","volume":"17","author":"Tamim","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562908000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562908000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/01\/vol27_i3_Antibiotic-Treatment.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T22:19:37Z","timestamp":1684534777000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1085562908000710"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2008.07.001","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}